Array

UNESP
AUIN | Agência Unesp de Inovação
   

Tecnology

NANOPARTICLES FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASES

Carimbo Unesp

Low Toxicity

Low cost
Biotechnology
Human Health
PROBLEM

Patients suffering from inflammatory bowel diseases, such as ulcerative rectocolitis and crohn’s disease, rely on multiple medications throughout their life to treat symptoms, prevent relapses, promote healing and prevent urgent surgical intervention. current drugs are not specifically targeted for the bowels and do not promote definitive healing, which may prolong the treatment and cause a variety of side effects in patients.

SOLUTION

The compounds developed here enable patients with inflammatory bowel diseases to be treated with nanoparticles that promote the release of drugs specifically in the intestines, potentiating their anti-inflammatory action through longer retention time and availability. drug- carrying nanoparticles provide better anti-inflammatory effects than the options currently available on the market and enable improvements in the patient’s quality of life.


Idea

Laboratory

Prototype

Scheduling

Market
Agency Code
17AUIN022
Patent
BR 10 2017019855-3

Agência Unesp de Inovação

Tel: +55 11 5627.0696

auin@unesp.br

https://auin.unesp.br

Date of deposit
15/09/2017
Inventor(s)
Data in the Unesp repository
Facebook AUIN Unesp Youtube AUIN Unesp Instagram AUIN Unesp